Core Insights - CarGurus reported quarterly earnings of $0.57 per share, exceeding the Zacks Consensus Estimate of $0.55 per share, and up from $0.45 per share a year ago, representing an earnings surprise of +3.64% [1] - The company achieved revenues of $238.7 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.27% and increasing from $231.36 million year-over-year [2] - CarGurus has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Financial Performance - The earnings surprise for the previous quarter was +5.56%, with actual earnings of $0.57 compared to an expected $0.54 [1] - The current consensus EPS estimate for the upcoming quarter is $0.60, with projected revenues of $237.28 million, and for the current fiscal year, the estimate is $2.17 on revenues of $932.17 million [7] Market Position - CarGurus shares have underperformed the market, losing about 6.8% since the beginning of the year, while the S&P 500 has gained 15.6% [3] - The Zacks Industry Rank places the Internet - Commerce sector in the bottom 41% of over 250 Zacks industries, indicating potential challenges for stock performance [8] Future Outlook - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and the trends in earnings estimate revisions [3][4] - The current Zacks Rank for CarGurus is 3 (Hold), suggesting that shares are expected to perform in line with the market in the near future [6]

分组1 - Codexis reported a quarterly loss of $0.22 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.15, and an improvement from a loss of $0.29 per share a year ago, indicating an earnings surprise of -46.67% [1] - The company posted revenues of $8.6 million for the quarter ended September 2025, missing the Zacks Consensus Estimate by 53.96%, and down from $12.83 million in the same quarter last year [2] - Codexis shares have declined approximately 54.9% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is -$0.10 on revenues of $23.61 million, and for the current fiscal year, it is -$0.67 on revenues of $65.14 million [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is in the top 41% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8]

Core Insights - Barings BDC reported quarterly earnings of $0.32 per share, exceeding the Zacks Consensus Estimate of $0.27 per share, and showing an increase from $0.29 per share a year ago, resulting in an earnings surprise of +18.52% [1] - The company generated revenues of $72.4 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 2.45% and up from $70.85 million year-over-year [2] - Barings BDC has outperformed consensus EPS estimates two times in the last four quarters and has topped consensus revenue estimates three times in the same period [2] Earnings Outlook - The sustainability of Barings BDC's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3] - The current consensus EPS estimate for the upcoming quarter is $0.26 on revenues of $68.6 million, while for the current fiscal year, the estimate is $1.07 on revenues of $278.1 million [7] Industry Context - The Financial - SBIC & Commercial Industry, to which Barings BDC belongs, is currently ranked in the bottom 23% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Barings BDC's stock performance [5]

Core Insights - Cherry Hill Mortgage (CHMI) reported quarterly earnings of $0.09 per share, missing the Zacks Consensus Estimate of $0.11 per share, representing an earnings surprise of -18.18% [1] - The company posted revenues of $3.3 million for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 22.22% [2] - Cherry Hill shares have declined approximately 11% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Earnings Performance - Over the last four quarters, Cherry Hill has exceeded consensus EPS estimates only once [2] - The current consensus EPS estimate for the upcoming quarter is $0.12 on $3 million in revenues, and $0.50 on $10.4 million in revenues for the current fiscal year [7] Market Outlook - The company's stock performance in the near term will largely depend on management's commentary during the earnings call [3] - The Zacks Rank for Cherry Hill is currently 3 (Hold), indicating expected performance in line with the market [6] - The REIT and Equity Trust industry, to which Cherry Hill belongs, is currently in the top 37% of Zacks industries, suggesting a favorable industry outlook [8]

Core Insights - Pembina Pipeline reported quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.45 per share, and down from $0.44 per share a year ago, representing an earnings surprise of -31.11% [1] - The company posted revenues of $1.3 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 1.95%, and down from $1.35 billion year-over-year [2] - Pembina Pipeline has underperformed the market with a 2.3% increase in shares since the beginning of the year, compared to the S&P 500's gain of 15.6% [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.55 on revenues of $1.12 billion, and for the current fiscal year, it is $2.17 on revenues of $5.78 billion [7] - The estimate revisions trend for Pembina Pipeline was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Oil and Gas - Production and Pipelines industry is currently in the top 34% of over 250 Zacks industries, suggesting that stocks in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, Enbridge, is expected to report quarterly earnings of $0.39 per share, reflecting a year-over-year change of -2.5%, with revenues anticipated at $10.86 billion, down 0.5% from the previous year [9][10]

Core Insights - Universal Electronics (UEIC) reported quarterly earnings of $0.08 per share, exceeding the Zacks Consensus Estimate of a loss of $0.03 per share, representing an earnings surprise of +366.67% [1] - The company posted revenues of $90.55 million for the quarter ended September 2025, which was below the Zacks Consensus Estimate by 3.39% and down from $102.07 million year-over-year [2] - Universal Electronics shares have declined approximately 68% year-to-date, contrasting with the S&P 500's gain of 15.6% [3] Earnings Performance - Over the last four quarters, Universal Electronics has surpassed consensus EPS estimates four times [2] - The company has topped consensus revenue estimates three times in the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is -$0.11 on revenues of $90.88 million, and for the current fiscal year, it is -$0.25 on revenues of $374.6 million [7] Market Outlook - The stock's immediate price movement will largely depend on management's commentary during the earnings call [3] - The Zacks Rank for Universal Electronics is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] - The Electronics - Miscellaneous Products industry is ranked in the top 21% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Core Viewpoint - Civitas Resources reported quarterly earnings of $1.93 per share, exceeding the Zacks Consensus Estimate of $1.34 per share, but down from $1.99 per share a year ago, indicating an earnings surprise of +44.03% [1][2] Financial Performance - The company posted revenues of $1.17 billion for the quarter ended September 2025, missing the Zacks Consensus Estimate by 1.09% and down from $1.27 billion year-over-year [2] - Over the last four quarters, Civitas has surpassed consensus EPS estimates two times, but has not beaten consensus revenue estimates [2] Stock Performance - Civitas shares have declined approximately 43.7% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] - The current Zacks Rank for Civitas is 4 (Sell), indicating expected underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.35 on revenues of $1.14 billion, and for the current fiscal year, it is $5.44 on revenues of $4.62 billion [7] - The trend of estimate revisions for Civitas was unfavorable prior to the earnings release, which may impact future stock movements [5][6] Industry Context - The Oil and Gas - Exploration and Production - United States industry is currently in the bottom 21% of over 250 Zacks industries, suggesting a challenging environment for stocks in this sector [8]

Core Insights - EverCommerce (EVCM) reported quarterly earnings of $0.03 per share, matching the Zacks Consensus Estimate, and showing improvement from a loss of $0.05 per share a year ago [1] - The company posted revenues of $147.47 million for the quarter ended September 2025, which was 0.39% below the Zacks Consensus Estimate and down from $176.26 million year-over-year [2] - EverCommerce shares have increased approximately 4.9% year-to-date, underperforming the S&P 500's gain of 15.6% [3] Earnings Performance - The company exceeded earnings expectations by delivering a surprise of +400% compared to the prior quarter's forecast of a loss of $0.01 per share [1] - Over the last four quarters, EverCommerce has surpassed consensus EPS estimates only once [1] Future Outlook - The company's earnings outlook will be crucial for determining future stock performance, with current consensus EPS estimates at $0.05 for the upcoming quarter and $0.10 for the current fiscal year [7] - The Zacks Rank for EverCommerce is currently 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Internet - Software industry, to which EverCommerce belongs, is currently ranked in the top 35% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Chesapeake Utilities reported quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $0.90 per share, but showing an increase from $0.80 per share a year ago, resulting in an earnings surprise of -8.89% [1] - The company achieved revenues of $179.6 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 4.48% and up from $160.14 million year-over-year [2] - Chesapeake Utilities has surpassed consensus revenue estimates four times over the last four quarters, although it has only exceeded EPS estimates once in the same period [2] Future Outlook - The immediate price movement of Chesapeake Utilities' stock will largely depend on management's commentary during the earnings call and the sustainability of earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $2.09 on revenues of $245.3 million, and for the current fiscal year, it is $6.14 on revenues of $915.6 million [7] - The Zacks Rank for Chesapeake Utilities is currently 4 (Sell), indicating expectations of underperformance in the near future [6] Industry Context - The Utility - Gas Distribution industry, to which Chesapeake Utilities belongs, is currently in the top 30% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Insights - Sutro Biopharma, Inc. reported a quarterly loss of $0.67 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.42, marking an earnings surprise of -59.52% [1] - The company generated revenues of $9.69 million for the quarter ended September 2025, exceeding the Zacks Consensus Estimate by 16.52% and showing an increase from $8.52 million year-over-year [2] - Sutro Biopharma's stock has declined approximately 46.5% since the beginning of the year, contrasting with the S&P 500's gain of 15.6% [3] Financial Performance - Over the last four quarters, Sutro Biopharma has surpassed consensus revenue estimates four times, but has only exceeded consensus EPS estimates once [2] - The current consensus EPS estimate for the upcoming quarter is -$0.44 on revenues of $8.89 million, and for the current fiscal year, it is -$1.84 on revenues of $96.57 million [7] Industry Context - Sutro Biopharma operates within the Medical - Biomedical and Genetics industry, which is currently ranked in the top 41% of over 250 Zacks industries [8] - The performance of Sutro Biopharma's stock may be influenced by the overall outlook for the industry, as top-ranked industries tend to outperform lower-ranked ones by a significant margin [8]